Bridge City Capital, LLC Corcept Therapeutics Inc Transaction History

Bridge City Capital, LLC

  • $325 Million
  • Q1 2025

A detailed history of Bridge City Capital, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Bridge City Capital, LLC holds 42,029 shares of CORT stock, worth $3.08 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
42,029
Previous 57,892 27.4%
Holding current value
$3.08 Million
Previous $2.92 Million 21.29%
% of portfolio
0.71%
Previous 0.79%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 14, 2025
SELL
$49.85 - $114.22 $790,770 - $1.81 Million
-15,863 Reduced 27.4%
42,029 $2.3 Million
Q4 2024

Feb 11, 2025
BUY
$44.66 - $60.85 $23,133 - $31,520
518 Added 0.9%
57,892 $2.92 Million
Q3 2024

Nov 14, 2024
BUY
$29.51 - $46.26 $240,122 - $376,417
8,137 Added 16.53%
57,374 $2.65 Million
Q2 2024

Aug 12, 2024
SELL
$22.21 - $34.48 $8,906 - $13,826
-401 Reduced 0.81%
49,237 $1.6 Million
Q1 2024

Apr 12, 2024
BUY
$21.1 - $27.46 $8,144 - $10,599
386 Added 0.78%
49,638 $1.25 Million
Q4 2023

Feb 13, 2024
BUY
$24.82 - $32.88 $143,136 - $189,618
5,767 Added 13.26%
49,252 $1.6 Million
Q3 2023

Nov 15, 2023
SELL
$21.97 - $33.8 $376,719 - $579,568
-17,147 Reduced 28.28%
43,485 $1.18 Million
Q2 2023

Aug 16, 2023
BUY
$21.44 - $25.15 $750 - $880
35 Added 0.06%
60,632 $1.35 Million
Q1 2023

May 15, 2023
SELL
$19.2 - $24.47 $4,358 - $5,554
-227 Reduced 0.37%
60,597 $1.31 Million
Q4 2022

Jan 25, 2023
SELL
$19.95 - $29.96 $8,578 - $12,882
-430 Reduced 0.7%
60,824 $1.24 Million
Q3 2022

Nov 08, 2022
SELL
$24.7 - $29.12 $557,330 - $657,063
-22,564 Reduced 26.92%
61,254 $1.57 Million
Q2 2022

Aug 15, 2022
SELL
$17.33 - $25.3 $2,582 - $3,769
-149 Reduced 0.18%
83,818 $1.99 Million
Q1 2022

May 18, 2022
SELL
$16.53 - $25.21 $7,289 - $11,117
-441 Reduced 0.52%
83,967 $1.89 Million
Q4 2021

Jan 20, 2022
SELL
$17.1 - $23.34 $256 - $350
-15 Reduced 0.02%
84,408 $1.67 Million
Q3 2021

Nov 10, 2021
SELL
$19.68 - $22.53 $443,095 - $507,262
-22,515 Reduced 21.05%
84,423 $1.66 Million
Q2 2021

Aug 11, 2021
SELL
$19.97 - $24.43 $71,372 - $87,312
-3,574 Reduced 3.23%
106,938 $2.35 Million
Q1 2021

Apr 28, 2021
SELL
$23.49 - $30.56 $26,473 - $34,441
-1,127 Reduced 1.01%
110,512 $2.63 Million
Q4 2020

Feb 12, 2021
SELL
$16.78 - $27.3 $19,448 - $31,640
-1,159 Reduced 1.03%
111,639 $2.92 Million
Q3 2020

Nov 16, 2020
BUY
$12.46 - $19.98 $273,347 - $438,321
21,938 Added 24.14%
112,798 $1.96 Million
Q2 2020

Jul 15, 2020
BUY
$11.0 - $18.26 $999,460 - $1.66 Million
90,860 New
90,860 $1.53 Million

Others Institutions Holding CORT

# of Institutions
477
Shares Held
84M
Call Options Held
1.43M
Put Options Held
2.75M
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.84B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Bridge City Capital, LLC Portfolio

Follow Bridge City Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridge City Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridge City Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email